Experiments involving the transfer of T lymphocytes expressing or not CXCR6, or blocking the CXCL16-CXCR6 interaction, have shown the requirement of CXCR6-CD8+T cells for the anti-tumor function of these T cells (12, 40, 57–59). The gene discussed is CD8A; the disease is neoplasm.